Clinical Trial Update: A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis [Phase 2]

View source ↗

Summary

A Phase II clinical study evaluating the efficacy and safety of SHR-2173 injection for active lupus nephritis, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• SHR-2173

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Active Lupus Nephritis | Phase 2 | Status: RECRUITING